|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 38/08 | (2006.01) |
| A61K 38/09 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2505204 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12165896.7 |
| Date of filing the European patent application | 2009-02-10 | |
| (97) | Date of publication of the European application | 2012-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-24 |
| (46) | Date of publication of the claims translation | 2015-04-27 |
| (30) | Number | Date | Country code |
| 27741 P | 2008-02-11 | US | |
| 08250703 | 2008-02-29 | EP |
| (72) |
Olesen, Tine Kold, US
Persson, Bo-Eric, CH
Cantor, Per, DK
van der Meulen, Egbert A, SE
Jensen, Jens-Christian, Slott, DK
|
| (73) |
Ferring B.V.,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Prostatos vėžio gydymo būdas su GNRH antagonistu degareliksu |
| Method of treating prostate cancer with the GnRH antagonist degarelix |
| Payment date | Validity (years) | Amount | |
| 2018-01-23 | 10 | 231.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2019-03-08 |